Kawuma Rachel, Ssemata Andrew Sentoogo, Bernays Sarah, Seeley Janet
MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
School of Public Health, University of Sydney, Sydney, Australia.
SSM Popul Health. 2021 Jan 30;13:100746. doi: 10.1016/j.ssmph.2021.100746. eCollection 2021 Mar.
Pre-exposure prophylaxis (PrEP), antiretroviral medication for prevention of HIV-acquisition, is part of biomedical HIV prevention strategies recommended for people at risk of HIV-infection. A decision to take PrEP depends on an assessment of 'being at risk' either by an individual, or healthcare provider. In this paper, we draw on the concept of 'candidacy' to examine the different ways in which women attending a dedicated clinic in Kampala, Uganda, for women at risk of HIV infection (including sex workers), assessed their suitability for PrEP. We conducted in-depth interviews with 30 HIV negative women up to four different times, to gather information on the motives for taking PrEP, and their life history and daily life. All the women described the relevance of PrEP to mitigate their risk of HIV infection. However, there were challenges to adherence because of alcohol use, irregular working hours and a fear of being seen taking pills that others might assume to be HIV treatment. The ways in which the different women used PrEP and interpreted the place of PrEP in their lives were not solely based on their assessment of protecting themselves during sex work. They also used PrEP to guard against infection from their regular partners, and as a tool to allow them to make more money safely, by having sex without a condom with clients. While eligibility to access PrEP was predicated on the women's being in an 'at risk' population group, an incentive to use PrEP was to protect themselves from HIV acquisition from a long-term partner and preserve the 'trust' in their intimate relationship by having condom-less sex. Applying a candidacy lens we highlight the complexity in how women experience and present as being 'at risk' and query the criteria on which categories of risk and PrEP eligibility are determined.
暴露前预防(PrEP),即用于预防感染艾滋病毒的抗逆转录病毒药物,是推荐给有感染艾滋病毒风险人群的生物医学艾滋病毒预防策略的一部分。是否决定采用PrEP取决于个人或医疗服务提供者对“处于风险中”的评估。在本文中,我们借鉴“候选资格”的概念,来审视乌干达坎帕拉一家专门为有感染艾滋病毒风险的女性(包括性工作者)开设的诊所中,女性评估自身是否适合采用PrEP的不同方式。我们对30名艾滋病毒阴性女性进行了多达四次的深入访谈,以收集她们采用PrEP的动机、生活史和日常生活方面的信息。所有女性都描述了PrEP对于降低她们感染艾滋病毒风险的相关性。然而,由于饮酒、工作时间不规律以及担心被人看到服药而被他人认为是在接受艾滋病毒治疗,在坚持用药方面存在挑战。不同女性使用PrEP的方式以及她们对PrEP在其生活中地位的理解,并非仅仅基于她们对在性工作中保护自己的评估。她们还使用PrEP来预防来自固定伴侣的感染,并且将其作为一种工具,通过与客户无保护措施地发生性行为来安全地赚取更多金钱。虽然获得PrEP的资格是以女性属于“处于风险中”的人群群体为前提的,但使用PrEP的一个动机是保护自己不被长期伴侣感染艾滋病毒,并通过无保护措施的性行为来维持她们亲密关系中的“信任”。通过运用候选资格这一视角,我们强调了女性如何体验并表现为“处于风险中”的复杂性,并质疑确定风险类别和PrEP资格的标准。